ArticleJournal of medicinal chemistry2009

Molecular dynamics study of non-nucleoside reverse transcriptase inhibitor 4-[[4-[[4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (TMC278/rilpivirine) aggregates: correlation between amphiphilic properties of the drug and oral bioavailability.

Yulia Volovik Frenkel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.